Tenders Are Invited For Pharmaceutical Products-Open House Medicinal Products Department Treats For The Active Ingredient Peginterferon Alfa-2A, Atc L03ab11

Pharmaceutical Products-Open House Medicinal Products Department Treats For The Active Ingredient Peginterferon Alfa-2A, Atc L03ab11. The Aok Rhineland -Palatinate/Saarland - The Health Insurance Company Offers All Interested Pharmaceutical Companies Without A Selection Decision. The Contractual Conclusions Are Made As Part Of An Open House Model. The Contracts Offered Are Not Exclusive; Contracts With All Market Participants (Pharmaceutical Companies) Are Desired By The Aok Rhineland -Palatinate/Saarland - The Health Insurance Company. In The Open House Model, Uniform Conditions Apply To All Participants. Contract Content, Conditions And Access Procedures Are Uniform - Individual Negotiations Are Not Conducted. The Contract Term Is A Maximum Of 24 Months, The Earliest Start Of The Contract Is July 1St, 2025. All Contracts End At The Latest 24 Months After The Day Of The Earliest Contract, Regardless Of The Date Of The Respective Contract. Access Or A Contract Can Be Concluded Within The 24-Month Period For The First Of Each Month. There Is A Right Of Termination For 6 Weeks At The End Of The Month In Accordance With The Provisions Of The Contract. Further Information On The Termination Options Is Included In The Contract Documents. The Aok Rhineland-Palatinate/Saarland-The Health Insurance Company Reserves The Right To Replace The Non-Exclusive Open House Discount Contracts With Exclusive Discount Contracts During The Contract Period As Part Of Europe-Wide Tender Procedures. With The Entry Into Force, The Open House Contracts Are Terminated In Accordance With The Contractual Regulation, I.E. The Open House Contracts Will End Automatically. Potential Contractual Partners Can Request The Contract Information And Contract Documents. The Documents Can Either Be Signed By Hand Or Electronically Submitted With A Qualified Electronic Signature. Documents Signed By Hand Are To Be Submitted To The Following Address In A 2-Way Version (In Advance As A Scan To The Email Address: [email protected]): Aok Rheinland-Pfalz/Saarland-The Health Insurance Fund, Strategic Contract Management Medicines, Virchowstraße 30, 67304 Eisenberg. Electronic Documents With A Qualified Electronic Signature Must Be Sent To The Mailbox By Email: [email protected]. After Registration, Potential Contractual Partners Can Apply For The Activation Documents And Access The Contract Information And The Contract Documents After Registration On The Open House Procedure On The Portal Www.Dtvp.De. A Link To The Portal Is In This Announcement (Under 5.1.11 Order Documents). Further Communication Takes Place Exclusively By Email Via The Above Box. Only Pharmaceutical Companies Are Considered As Potential Contractual Partners. The Documents Of The Open House Procedure Are Exclusively